(Q40088394)

English

ACTH and neuromuscular transmission: Electrophysiological in vitro investigation of the effects of corticotropin and an ACTH fragment on neuromuscular transmission

scientific article published on March 1, 1977

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

ACTH and neuromuscular transmission: Electrophysiological in vitro investigation of the effects of corticotropin and an ACTH fragment on neuromuscular transmission (English)

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

author name string

K. L. Birnberger

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196543

29 December 2022

R. Rüdel

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196543

29 December 2022

A. Struppler

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A196543

29 December 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=196543

29 December 2022

publication date

1 March 1977

1 reference

Europe PubMed Central

17 September 2017

full work available at URL

http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410010313

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410010313

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410010313

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Annals of Neurology

1 reference

Europe PubMed Central

17 September 2017

1

1 reference

Europe PubMed Central

17 September 2017

3

1 reference

Europe PubMed Central

17 September 2017

270-275

1 reference

Europe PubMed Central

17 September 2017

Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs

1 reference

https://api.crossref.org/works/10.1002%2FANA.410010313

21 January 2018

The active sequence in the ACTH molecule responsible for inhibition of the extinction of conditioned avoidance behaviour in rats.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410010313

21 January 2018

Antibiotic blockade of neuromuscular function

1 reference

https://api.crossref.org/works/10.1002%2FANA.410010313

21 January 2018

Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin

1 reference

https://api.crossref.org/works/10.1002%2FANA.410010313

21 January 2018

TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE

1 reference

https://api.crossref.org/works/10.1002%2FANA.410010313

21 January 2018

Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors

3

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Treatment of severe myasthenia gravis with large doses of ACTH

5

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Corticotropin therapy in myasthenia gravis: effects, indications, and limitations

6

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy

7

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Benefit from alternate-day prednisone in myasthenia gravis

8

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

The treatment of severe myasthenia gravis with immunosuppressive agents

9

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Changes in serum complement activity in patients with myasthenia gravis

11

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors

12

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Autoimmune Response to Acetylcholine Receptor

13

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Glucocorticoids and Mammalian Motor Nerve Excitability

15

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Corticosteroids: a direct effect at the neuromuscular junction

16

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Effect of pituitary hormones, cortisone and adrenalectomy on some aspects of neuromuscular function and acetylcholine synthesis.

17

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

A possible direct action of ACTH on nerve and muscle.

18

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

A Modulatory Effect of Pituitary Polypeptides on Peripheral Nerve and Muscle

20

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

The quantal components of the mammalian end-plate potential

23

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

On the factors which determine the amplitude of the miniature end-plate potential

24

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Mechanism of Colistin-Induced Neuromuscular Depression

25

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

The end-plate potential in mammalian muscle

26

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Effects of catecholamines on the neuromuscular junction in the rat diaphragm

27

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Ionic dependence of adrenal steroidogenesis and ACTH-induced changes in the membrane potential of adrenocortical cells

28

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Cell membrane permeability change: an important step in hormone action

29

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

The effects of depolarization of motor nerve terminals upon the release of transmitter by nerve impulses

30

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Presynaptic failure of neuromuscular propagation in rats

31

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Myasthenic Syndrome Associated With Antibiotics

33

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Depolarization and calcium entry in squid giant axons

35

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

The effect of calcium and magnesium on the spontaneous release of transmitter from mammalian motor nerve endings

36

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS.

37

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Radioimmunoassay of ACTH in plasma

38

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Myasthenia gravis and acetylcholine receptor. Effect of steroids in clinical course and cellular immune response to acetylcholine receptor

39

1 reference

10.1002/ANA.410010313

https://api.crossref.org/works/10.1002/ANA.410010313

29 December 2022

Identifiers

10.1002/ANA.410010313

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40088394&oldid=1797687768"